Invesco’s TG Therapeutics TGTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $23.9M | Sell |
720,934
-888,881
| -55% | -$26.5M | ﹤0.01% | 1362 |
|
|
2025
Q4 | $48M | Buy |
1,609,815
+515,481
| +47% | +$16.8M | ﹤0.01% | 1102 |
|
|
2025
Q3 | $39.5M | Buy |
1,094,334
+124,429
| +13% | +$4.1M | 0.01% | 1165 |
|
|
2025
Q2 | $34.9M | Sell |
969,905
-240,937
| -20% | -$8.97M | 0.01% | 1202 |
|
|
2025
Q1 | $47.7M | Buy |
1,210,842
+281,099
| +30% | +$9.46M | 0.01% | 1053 |
|
|
2024
Q4 | $28M | Buy |
929,743
+10,989
| +1% | +$315K | 0.01% | 1325 |
|
|
2024
Q3 | $21.5M | Buy |
918,754
+448,438
| +95% | +$9.79M | ﹤0.01% | 1438 |
|
|
2024
Q2 | $8.37M | Sell |
470,316
-93,323
| -17% | -$1.49M | ﹤0.01% | 1905 |
|
|
2024
Q1 | $8.57M | Sell |
563,639
-146,108
| -21% | -$2.33M | ﹤0.01% | 1907 |
|
|
2023
Q4 | $12.1M | Buy |
709,747
+364,924
| +106% | +$4.24M | ﹤0.01% | 1697 |
|
|
2023
Q3 | $2.88M | Buy |
344,823
+36,723
| +12% | +$512K | ﹤0.01% | 2458 |
|
|
2023
Q2 | $7.65M | Buy |
308,100
+61,083
| +25% | +$1.58M | ﹤0.01% | 1993 |
|
|
2023
Q1 | $3.72M | Sell |
247,017
-27,896
| -10% | -$424K | ﹤0.01% | 2365 |
|
|
2022
Q4 | $3.25M | Buy |
274,913
+166,597
| +154% | +$1.21M | ﹤0.01% | 2443 |
|
|
2022
Q3 | $642K | Sell |
108,316
-237,417
| -69% | -$1.56M | ﹤0.01% | 3120 |
|
|
2022
Q2 | $1.47M | Buy |
345,733
+15,273
| +5% | +$95.4K | ﹤0.01% | 2835 |
|
|
2022
Q1 | $3.14M | Sell |
330,460
-1,321,819
| -80% | -$15.3M | ﹤0.01% | 2603 |
|
|
2021
Q4 | $31.4M | Sell |
1,652,279
-146,114
| -8% | -$3.79M | 0.01% | 1263 |
|
|
2021
Q3 | $59.8M | Buy |
1,798,393
+677,100
| +60% | +$20.9M | 0.02% | 981 |
|
|
2021
Q2 | $43.5M | Buy |
1,121,293
+20,398
| +2% | +$801K | 0.01% | 1133 |
|
|
2021
Q1 | $53.1M | Sell |
1,100,895
-680,397
| -38% | -$32.7M | 0.01% | 1037 |
|
|
2020
Q4 | $92.7M | Buy |
1,781,292
+720,738
| +68% | +$24.4M | 0.03% | 760 |
|
|
2020
Q3 | $28.4M | Buy |
+1,060,554
| New | +$24.4M | 0.01% | 1146 |
|
|
2018
Q4 | – | Sell |
-102,476
| Closed | -$574K | – | 3872 |
|
|
2018
Q3 | $574K | Sell |
102,476
-75,210
| -42% | -$859K | ﹤0.01% | 3371 |
|
|
2018
Q2 | $2.34M | Buy |
+177,686
| New | +$2.44M | ﹤0.01% | 2658 |
|
|
2018
Q1 | – | Sell |
-89,424
| Closed | -$733K | – | 3766 |
|
|
2017
Q4 | $733K | Buy |
+89,424
| New | +$781K | ﹤0.01% | 3146 |
|
|
2015
Q3 | – | Sell |
-323
| Closed | -$5K | – | 3979 |
|
|
2015
Q2 | $5K | Sell |
323
-108,163
| -100% | -$1.71M | ﹤0.01% | 4215 |
|
|
2015
Q1 | $1.68M | Buy |
108,486
+18,805
| +21% | +$285K | ﹤0.01% | 2721 |
|
|
2014
Q4 | $1.42M | Sell |
89,681
-40,951
| -31% | -$533K | ﹤0.01% | 2733 |
|
|
2014
Q3 | $1.39M | Sell |
130,632
-50,942
| -28% | -$472K | ﹤0.01% | 2756 |
|
|
2014
Q2 | $1.71M | Buy |
181,574
+140,542
| +343% | +$899K | ﹤0.01% | 2682 |
|
|
2014
Q1 | $283K | Buy |
+41,032
| New | +$243K | ﹤0.01% | 3614 |
|
Other funds holding TGTX
VPM
VCM
SCM
CAM
Invesco's TGTX Position: Q1 2026 in Review
Invesco reduced its TG Therapeutics (TGTX) stake by 55% in Q1 2026, selling an estimated $26.5M and leaving 720,934 shares worth $23.9M. The position accounts for ﹤0.01% of the portfolio, ranked #1362.
Invesco first reported a position in TGTX in Q1 2014 and has held it in 32 quarters since. The position peaked at $92.7M in Q4 2020. 363 funds tracked by Wall St. Rank hold TGTX as of Q1 2026.
- Invesco held 720,934 shares of TG Therapeutics worth $23.9M as of Q1 2026.
- Invesco sold 888,881 TG Therapeutics shares in Q1 2026, an estimated $26.5M.
- TG Therapeutics made up ﹤0.01% of Invesco's portfolio in Q1 2026, its #1362 holding.
- Invesco first reported a position in TG Therapeutics in Q1 2014 and has held it in 32 quarters since.
- Invesco's TG Therapeutics position peaked at $92.7M in Q4 2020.
- 363 funds tracked by Wall St. Rank held TG Therapeutics as of Q1 2026.
Based on Invesco's 13F filing for Q1 2026, filed 12 May 2026.